FindMyRecallSubscribe
Class I: serious health riskOngoing

Unichem Pharmaceuticals Cyclobenzaprine Hydrochloride Tablets Recall

Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufac…

Unichem Pharmaceuticals USA Inc. · East Brunswick, NJ

Risk level
Class I
Reported by FDA
Sep 24, 2025
Recall ID
D-0655-2025
Check your lot numberHow we source this data

Summary

Unichem Pharmaceuticals recalled Cyclobenzaprine Hydrochloride Tablets starting Aug 27, 2025. The FDA classified it as Class I (serious health risk) and published enforcement report D-0655-2025 on Sep 24, 2025. Reason: Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color). Status: Ongoing.

Why it was recalled

Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).

Product description

Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd, Pilerne Ind. Estate, Pilerne, Bardez, Goa, India; Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ. NDC 29300-415-19.

Lot numbers, UPCs & expiration codes

Lot No: GMML24026A, Expires: 09/30/2027

Where it was sold

Nationwide within the U.S.A

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0655-2025
Classification
Class I
Status
Ongoing
Recall initiated
Aug 27, 2025
FDA report date
Sep 24, 2025
Quantity
230 90-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Unichem Pharmaceuticals USA Inc.

Original FDA data

Every field from FDA enforcement report D-0655-2025, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Ongoing
Country
United States
Event ID
97482
Address
1 Tower Center Blvd Ste 2200
Code information
Lot No: GMML24026A, Expires: 09/30/2027
Postal code
08816-1145
Report date
Sep 24, 2025
Product type
Drugs
Recall number
D-0655-2025
Classification
Class I
Recalling firm
Unichem Pharmaceuticals USA Inc.
Product quantity
230 90-count bottles
Reason for recall
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd, Pilerne Ind. Estate, Pilerne, Bardez, Goa, India; Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ. NDC 29300-415-19.
Distribution pattern
Nationwide within the U.S.A
Recall initiation date
Aug 27, 2025
Initial firm notification
Press Release
Center classification date
Sep 17, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0655-2025, published Sep 24, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls